Built to provide financial advisors and investors with the knowledge and insights to navigate the rapidly evolving world of private market secondaries.
Coller Secondaries Private Equity Opportunities Fund
IMPORTANT NOTICE: The content and materials within this website are directed for investors residing in certain jurisdictions only. By selecting the relevant options below, you certify that this accurately reflects where you reside.
In December 2006, CIP IV formed a €193m joint venture with ABN AMRO Capital. Forbion Capital Partners span out of the bank to manage the portfolio of 26 life science companies.